Customer Service 1 (888) 261-2693
Please enter Search keyword. Advanced Search
Home About Us Resources Archive Free Reports Market Window

We're up 100%... Does the Bull Market Have to End Now? Absolutely Not!

By Dr. Steve Sjuggerud
Monday, July 18, 2011

It might be one of the boldest things I've ever written...
 
In the April 2009 issue of True Wealth, I wrote...
 
I am extremely bullish on stocks, starting now. I believe the entire stock market could rise by 50% from its lows last week over the next 18 months. And the next seven to 10 years could be phenomenal...
 
Predicting a 50% gain in the stock market was a foolish thing to do. The stock market never rises that much, that quickly.
 
You have to keep in mind, March 2009 was the stock market's bottom. Despair was thick in the air. I might have been the most bullish investor out there at the time.
 
As it turned out, my big, bold prediction turned out to be conservative... Stocks were up 50% in 12 months after I wrote that. From the bottom in March 2009 to the top this year, stocks doubled.
 
But where do we go from here? After all, stocks have doubled since their March 2009 lows...
 
Doesn't this bull run in stocks have to end already? Absolutely not.
 
It's still "the best time to buy in a generation" – as I wrote in the June 2011 issue of True Wealth.
 
And I want to repeat our key theme from that issue...
 
I never imagined we'd see all these things come together at the same time in my investing lifetime. Right now, we have:
 
•  Major stocks trading at record-low valuations, while we have near-zero interest rates.
•  House prices more affordable than ever, with record-low mortgage rates.
•  Gold investments that are record-cheap, during a bull market in gold.
•  We also have a fearful public, which is good, because it means the peak is not here yet. And we have a sputtering economy, which is good, because we have a government that is committed to keeping interest rates near zero for a long time.
 
In short, the "setup" conditions are still in place for this bull market to continue.
 
The script has stayed the same for years now – it's the Bernanke Asset Bubble... And it should continue for longer than anyone can imagine.
 
Close your ears to just about everything else. Rest easy knowing you have the script in your hands.
 
Buy everything (just about). A soaring stock market is just "collateral damage" on the way to getting the economy going. So is a weakening dollar (which means higher gold prices).
 
If you're following the script, you know there's money at your feet. All you have to do is own stocks and gold, and that money is yours.
 
Good investing,
 
Steve




Further Reading:

Steve is not just bullish on stocks. He also sees some gold stocks rising triple digits from here. "Gold is in a clear uptrend," he writes. "Yet investors are apathetic. This is what I like to see!" Read more here: Right Now Is the Best Time to Buy Gold Since 2008.

Market Notes


NEW HIGHS OF NOTE LAST WEEK
 
Petrohawk Energy (HK)... Eagle Ford play
Cabot Oil & Gas (COG)... oil & gas
Rosetta Resources (ROSE)... oil & gas
EV Energy Partners (EVEP)... oil & gas
Southwestern Energy (SWN)... oil & gas
Netflix (NFLX)... home movies
Royal Gold (RGLD)... gold royalties
Wynn Resorts (WYNN)... casinos

NEW LOWS OF NOTE LAST WEEK
 
Southwest Airlines (LUV)... airline
Delta Airlines (DAL)... airline
Bank of America (BAC)... banking
Morgan Stanley (MS)... banking
Nokia (NOK)... cell phones
GOL Linhas (GOL)... Brazilian airline
Gafisa (GFA)... Brazilian homebuilder
Shaw Group (SHAW)... infrastructure builder

In The Daily Crux



Recent Articles
Legal Notices: Stansberry Research LLC (Stansberry Research) is a publishing company and the indicators, strategies, reports, articles and all other features of our products are provided for informational and educational purposes only and should not be construed as personalized investment advice. Our recommendations and analysis are based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.

 

Readers should be aware that trading stocks and all other financial instruments involves risk. Past performance is no guarantee of future results, and we make no representation that any customer will or is likely to achieve similar results.

 

Our testimonials are the words of real subscribers received in real letters, emails, and other feedback who have not been paid for their testimonials. Testimonials are printed under aliases to protect privacy, and edited for length. Their claims have not been independently verified or audited for accuracy. We do not know how much money was risked, what portion of their total portfolio was allocated, or how long they owned the security. We do not claim that the results experienced by such subscribers are typical and you will likely have different results.

 

Any performance results of our recommendations prepared by Stansberry Research are not based on actual trading of securities but are instead based on a hypothetical trading account. Hypothetical performance results have many inherent limitations. Your actual results may vary.

 

Stansberry Research expressly forbids its writers from having a financial interest in any security they recommend to our subscribers. And all Stansberry Research (and affiliated companies), employees, and agents must wait 24 hours after an initial trade recommendation is published on the Internet, or 72 hours after a direct mail publication is sent, before acting on that recommendation.

 

© 2024 Stansberry Research, LLC. | Privacy Policy| Customer Service
Stansberry Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This website may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry Research, LLC. 1125 N Charles St. Suite 500, Baltimore MD 21202.